Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C2H3O5P.2Na.H2O |
| Molecular Weight | 202.0108 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.[Na+].[Na+].OP([O-])(=O)CC([O-])=O
InChI
InChIKey=AABSNGAQFNHPMF-UHFFFAOYSA-L
InChI=1S/C2H5O5P.2Na.H2O/c3-2(4)1-8(5,6)7;;;/h1H2,(H,3,4)(H2,5,6,7);;;1H2/q;2*+1;/p-2
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Autophagy suppresses tumor progression by limiting chromosomal instability. | 2007-06-01 |
|
| Glycosaminoglycan interactions in murine gammaherpesvirus-68 infection. | 2007-04-04 |
|
| Design, synthesis, and bioactivity of novel inhibitors of E. coli aspartate transcarbamoylase. | 2007-04-01 |
|
| Inhibition of gene amplification in telomerase deficient immortalized mouse embryonic fibroblasts. | 2007-03 |
|
| Enriching suicide gene bearing tumor cells for an increased bystander effect. | 2007-01 |
|
| Unique uptake and efflux systems of inorganic phosphate in osteoclast-like cells. | 2007-01 |
|
| Phosphonoacetic acid utilization by fungal isolates: occurrence and properties of a phosphonoacetate hydrolase in some penicillia. | 2006-12 |
|
| Imaging immediate-early and strict-late promoter activity during oncolytic herpes simplex virus type 1 infection and replication in tumors. | 2006-12 |
|
| Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus. | 2006-11 |
|
| N-phosphonacetyl-L-isoasparagine a potent and specific inhibitor of Escherichia coli aspartate transcarbamoylase. | 2006-10-05 |
|
| Picosecond dynamics of T and R forms of aspartate transcarbamylase: a neutron scattering study. | 2006-10 |
|
| Selective excision of chain-terminating nucleotides by HIV-1 reverse transcriptase with phosphonoformate as substrate. | 2006-09-22 |
|
| Alpha-herpesvirus infection induces the formation of nuclear actin filaments. | 2006-08 |
|
| A role for carbon catabolite repression in the metabolism of phosphonoacetate by Agromyces fucosus Vs2. | 2006-08 |
|
| Development of a common fully stereocontrolled access to the medicinally important and promising prostacyclin analogues iloprost, 3-oxa-iloprost and cicaprost. | 2006-07-17 |
|
| Fully stereocontrolled syntheses of 3-oxacarbacyclin and carbacyclin by the conjugate addition-azoalkene-asymmetric olefination strategy. | 2006-06-09 |
|
| Bond strength to primed Ti-6Al-7Nb alloy of two acrylic resin adhesives. | 2006-06 |
|
| Detection of phosphonoacetate degradation and phnA genes in soil bacteria from distinct geographical origins suggest its possible biogenic origin. | 2006-05 |
|
| Functional annotation and kinetic characterization of PhnO from Salmonella enterica. | 2006-03-07 |
|
| Continued survival of more than ten years, without resection of metastatic disease, in patients with metastatic colorectal cancer treated with biomodulated fluorouracil: report of two cases. | 2006-03 |
|
| Phosphonoacetate hydrolase from Penicillium oxalicum: purification and properties, phosphate starvation-independent expression, and partial sequencing. | 2006-03 |
|
| Inhibition of adenosine kinase by phosphonate and bisphosphonate derivatives. | 2006-02 |
|
| Severe cytochrome c oxidase inhibition in vivo does not induce a pyrimidine deficiency; neuroprotective action of oral uridine prodrug PN401 requires supraphysiological levels of uridine. | 2005-12-20 |
|
| Antiviral activity of the marine alga Symphyocladia latiuscula against herpes simplex virus (HSV-1) in vitro and its therapeutic efficacy against HSV-1 infection in mice. | 2005-12 |
|
| Functional inaccessibility of quiescent herpes simplex virus genomes. | 2005-11-21 |
|
| Adenosine phosphonoacetic acid is slowly metabolized by NDP kinase. | 2005-11 |
|
| Synthesis of farnesol isomers via a modified Wittig procedure. | 2005-10-27 |
|
| Precursor decomposition and nucleation kinetics during platelike apatite synthesis. | 2005-09-15 |
|
| [Photodynamic inhibition of infection caused by herpes simplex virus type 1 in the cultured cells, by using 5-aminolevulinic acid-induced porphyrins]. | 2005-08-18 |
|
| Efficient synthesis of fluorothiosparfosic acid analogues with potential antitumoral activity. | 2005-08-15 |
|
| Anion binding and controlled aggregation of human interleukin-1 receptor antagonist. | 2005-07-26 |
|
| Effect of ligand structure on the pathways for iron release from human serum transferrin. | 2005-07-11 |
|
| A single amino acid substitution in the active site of Escherichia coli aspartate transcarbamoylase prevents the allosteric transition. | 2005-06-03 |
|
| Aspartate transcarbamylase from the hyperthermophilic archaeon Pyrococcus abyssi. Insights into cooperative and allosteric mechanisms. | 2005-06 |
|
| Sensitivity to phosphonoacetic acid: a new phenotype to probe DNA polymerase delta in Saccharomyces cerevisiae. | 2005-06 |
|
| Genomic instability in Gadd45a-/- cells is coupled with S-phase checkpoint defects. | 2005-05 |
|
| The antiviral activity of the combinations of netropsin derivatives with modified nucleosides and phosphonoacetic acid as estimated in the model of herpesvirus type 1 in a vero cell culture. | 2005-04-26 |
|
| Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides. | 2005-03 |
|
| The human cytomegalovirus UL78 gene is highly conserved among clinical isolates, but is dispensable for replication in fibroblasts and a renal artery organ-culture system. | 2005-02 |
|
| Phosphonate catabolism by Campylobacter spp. | 2005-02 |
|
| A facile synthesis of novel chiral phosphonoacetates bearing a stereogenic phosphorus atom. | 2005-01 |
|
| Cyclic sulfamidates as vehicles for the synthesis of substituted lactams. | 2004-12-09 |
|
| A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: a Southwest Oncology Group study. | 2004-11 |
|
| Characterization and expression of the pseudorabies virus early gene UL54. | 2004-08 |
|
| Uncharged AZT and D4T derivatives of phosphonoformic and phosphonoacetic acids as anti-HIV pronucleosides. | 2004-07-01 |
|
| Tetrahedral intermediates in thiamin diphosphate-dependent decarboxylations exist as a 1',4'-imino tautomeric form of the coenzyme, unlike the michaelis complex or the free coenzyme. | 2004-06-01 |
|
| Aspartate transcarbamylase (ATCase) of Escherichia coli: a new crystalline R-state bound to PALA, or to product analogues citrate and phosphate. | 2004-06-01 |
|
| In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir? | 2004-03 |
|
| In vitro antiviral activity of polyoxotungstate (PM-19) and other polyoxometalates against herpes simplex virus. | 1991-12 |
|
| Inhibition of herpes simplex virus replication by phosphonoacetic acid. | 1974-09 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C281
Created by
admin on Mon Mar 31 18:25:19 GMT 2025 , Edited by admin on Mon Mar 31 18:25:19 GMT 2025
|
||
|
NCI_THESAURUS |
C29575
Created by
admin on Mon Mar 31 18:25:19 GMT 2025 , Edited by admin on Mon Mar 31 18:25:19 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID20970211
Created by
admin on Mon Mar 31 18:25:19 GMT 2025 , Edited by admin on Mon Mar 31 18:25:19 GMT 2025
|
PRIMARY | |||
|
20055354
Created by
admin on Mon Mar 31 18:25:19 GMT 2025 , Edited by admin on Mon Mar 31 18:25:19 GMT 2025
|
PRIMARY | |||
|
CHEMBL50300
Created by
admin on Mon Mar 31 18:25:19 GMT 2025 , Edited by admin on Mon Mar 31 18:25:19 GMT 2025
|
PRIMARY | |||
|
BY5RLE340B
Created by
admin on Mon Mar 31 18:25:19 GMT 2025 , Edited by admin on Mon Mar 31 18:25:19 GMT 2025
|
PRIMARY | |||
|
C76496
Created by
admin on Mon Mar 31 18:25:19 GMT 2025 , Edited by admin on Mon Mar 31 18:25:19 GMT 2025
|
PRIMARY | |||
|
54870-27-8
Created by
admin on Mon Mar 31 18:25:19 GMT 2025 , Edited by admin on Mon Mar 31 18:25:19 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD